|
|
||||||||
ORIGINAL RESEARCH |
From the 1Division of Adolescent Medicine, 2Center for Epidemiology and Biostatistics, and 3Division of General and Community Pediatrics, Cincinnati Childrens Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio.
OBJECTIVE: To determine the prevalence of high-risk (cancer-associated) human papillomavirus (HPV) infection in U.S. women, identify sociodemographic factors associated with infection, and explore the implications for prevention of HPV-related disease in the vaccination era.
METHODS: Women aged 1459 years (n=1,921) participating in the 20032004 National Health and Nutrition Examination Survey provided a vaginal swab which was evaluated for 37 HPV types. We determined which sociodemographic characteristics were associated with high-risk HPV, using logistic regression models.
RESULTS: High-risk HPV infection was present in 15.6% (95% confidence interval [CI] 12.618.6%) of participants, corresponding to a population prevalence of 12,028,293 U.S. women. Women living below the poverty line, compared with those living three or more times above it, were more likely to be positive for high-risk HPV (23% versus 12%, P = .03). Among participants living below the poverty line, only Mexican-American ethnicity (odds ratio [OR] 0.4, 95% CI 0.20.9) and unmarried status (OR 3.3, 95% CI 1.28.9) were associated with HPV prevalence. In contrast, several factors were associated with HPV among participants living above the poverty line, including black race (OR 1.4, 95% CI 1.02.0), income (OR 0.92, 95% CI 0.840.99), unmarried status (OR 2.0, 95% CI 1.33.0), and age (OR for 2225 year olds 2.4, 95% CI 1.44.0).
CONCLUSION: High-risk HPV infection is common in U.S. women, particularly in poor women. Cervical cancer prevention efforts in the vaccination era must ensure that all low-income women have access to preventive services including education, Pap test screening, and HPV vaccines. Otherwise, existing disparities in cervical cancer could worsen.
LEVEL OF EVIDENCE: III
This article has been cited by other articles:
![]() |
J. A. Kahn, S. L. Rosenthal, Y. Jin, B. Huang, A. Namakydoust, and G. D. Zimet Rates of Human Papillomavirus Vaccination, Attitudes About Vaccination, and Human Papillomavirus Prevalence in Young Women Obstet. Gynecol., May 1, 2008; 111(5): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zubor, J. Danko, K. Kajo, and N. Szunyogh Low Affordability May Limit the Effect of Cervical Cancer Vaccination in Central and Eastern European Countries J. Clin. Oncol., December 1, 2007; 25(34): 5534 - 5537. [Full Text] [PDF] |
||||
![]() |
M. Dawar MD MHSc, S. Deeks MD MHSc, and S. Dobson MD Human papillomavirus vaccines launch a new era in cervical cancer prevention Can. Med. Assoc. J., August 28, 2007; 177(5): 456 - 461. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |